Effect of Treatment for 12 Weeks With Rilapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, on Arterial Inflammation as Assessed With 18F-Fluorodeoxyglucose-Positron Emission Tomography Imaging

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ELSEVIER SCIENCE INC

1. Academy of Medical Sciences (AMS) [AMS-SGCL1-Rudd] Funding Source: researchfish
2. British Heart Foundation [PG/09/083/27667, FS/12/29/29463] Funding Source: researchfish
3. British Heart Foundation [PG/09/083/27667, FS/12/29/29463] Funding Source: Medline